生物活性

• 描述GLPG0634 analog is a pan JAK inhibitor with IC50s of 50-200 nM for JAK1/JAK2/JAK3.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT02885181	Rheumatoid Arthritis	Phase 2	Completed	-	United States, Florida ... more >> Omega Research Consultants DeBary, Florida, United States, 32713 Sarasota Arthritis Research Center Sarasota, Florida, United States, 34239 United States, Georgia Medical Associates of North Georgia Canton, Georgia, United States, 30114 United States, Kentucky Center For Arthritis and Osteoporosis Elizabethtown, Kentucky, United States, 42701 United States, New Mexico Albuquerque Center For Rheumatology Albuquerque, New Mexico, United States, 87102 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 United States, Texas Accurate Clinical Management - Najam Houston, Texas, United States, 77084 Accurate Clinical Research Inc. Stafford, Texas, United States, 77477 Medical Center Research LLC Webster, Texas, United States, 77598 Bulgaria MHAT-Plovdiv AD Plovdiv, Bulgaria, 4000 Umhat Kaspela Plovdiv, Bulgaria, 4003 NMTH Tsar Boris III Sofia, Bulgaria, 1233 Czechia A-Shine s.r.o. Plzen, Czechia, 31200 Medical Plus, S.R.O. Uherske Hradiste, Czechia, 68601 Georgia LLC Arensia Exploratory Medicine T'bilisi, Georgia, 0112 Moldova, Republic of ARENSIA Exploratory Medicine Phase I Unit, Republican Clinical Hospital Chisinau, Moldova, Republic of, MD-2025 Poland ClinicMed Badurski i wspolnicy Spolka Jawna Bialystok, Poland, 15-879 Ukraine Kharkiv City Hospital 8 Kharkiv, Ukraine, 140176 Medical Center_Clinic of International Institute of clinical Studies Kyiv, Ukraine, 2068 Collapse <<
  NCT02885181	-	-	Completed	-	-